FT576

Overview

FT576 is an investigational, universal, off-the-shelf NK cell cancer immunotherapy.

SparkCures ID 430
Developed By Fate Therapeutics
Generic Name FT576
Treatment Classifications
  • Natural Killer (NK) Cells (Allogeneic)

Clinical Trials

All Clinical Trials

View all active clinical trials around the US.

Early Relapse Multiple Myeloma

The following is a listing of clinical trials for patients with multiple myeloma who have received one to two prior lines of therapy.

Late Relapse Multiple Myeloma

The following is a listing of clinical trials for patients with multiple myeloma who have received three or more prior lines of therapy.

Smoldering Myeloma
Monoclonal Gammopathy of Undetermined Significance (MGUS)

Resources